Literature DB >> 35263570

Human epigenetic and transcriptional T cell differentiation atlas for identifying functional T cell-specific enhancers.

Josephine R Giles1, Sasikanth Manne2, Elizabeth Freilich3, Derek A Oldridge4, Amy E Baxter2, Sangeeth George5, Zeyu Chen2, Hua Huang6, Lakshmi Chilukuri5, Mary Carberry7, Lydia Giles7, Nan-Ping P Weng8, Regina M Young9, Carl H June10, Lynn M Schuchter7, Ravi K Amaravadi7, Xiaowei Xu11, Giorgos C Karakousis12, Tara C Mitchell7, Alexander C Huang13, Junwei Shi3, E John Wherry14.   

Abstract

The clinical benefit of T cell immunotherapies remains limited by incomplete understanding of T cell differentiation and dysfunction. We generated an epigenetic and transcriptional atlas of T cell differentiation from healthy humans that included exhausted CD8 T cells and applied this resource in three ways. First, we identified modules of gene expression and chromatin accessibility, revealing molecular coordination of differentiation after activation and between central memory and effector memory. Second, we applied this healthy molecular framework to three settings-a neoadjuvant anti-PD1 melanoma trial, a basal cell carcinoma scATAC-seq dataset, and autoimmune disease-associated SNPs-yielding insights into disease-specific biology. Third, we predicted genome-wide cis-regulatory elements and validated this approach for key effector genes using CRISPR interference, providing functional annotation and demonstrating the ability to identify targets for non-coding cellular engineering. These studies define epigenetic and transcriptional regulation of human T cells and illustrate the utility of interrogating disease in the context of a healthy T cell atlas.
Copyright © 2022. Published by Elsevier Inc.

Entities:  

Keywords:  CD8 T cell differentiation; CRISPR; epigenetic regulation; epigenome engineering

Mesh:

Substances:

Year:  2022        PMID: 35263570      PMCID: PMC9214622          DOI: 10.1016/j.immuni.2022.02.004

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   43.474


  100 in total

1.  The sva package for removing batch effects and other unwanted variation in high-throughput experiments.

Authors:  Jeffrey T Leek; W Evan Johnson; Hilary S Parker; Andrew E Jaffe; John D Storey
Journal:  Bioinformatics       Date:  2012-01-17       Impact factor: 6.937

2.  Tumor-Residing Batf3 Dendritic Cells Are Required for Effector T Cell Trafficking and Adoptive T Cell Therapy.

Authors:  Stefani Spranger; Daisy Dai; Brendan Horton; Thomas F Gajewski
Journal:  Cancer Cell       Date:  2017-05-08       Impact factor: 31.743

3.  CD4+ T Cell Help Is Required for the Formation of a Cytolytic CD8+ T Cell Subset that Protects against Chronic Infection and Cancer.

Authors:  Ryan Zander; David Schauder; Gang Xin; Christine Nguyen; Xiaopeng Wu; Allan Zajac; Weiguo Cui
Journal:  Immunity       Date:  2019-12-03       Impact factor: 31.745

4.  Epigenomic-Guided Mass Cytometry Profiling Reveals Disease-Specific Features of Exhausted CD8 T Cells.

Authors:  Bertram Bengsch; Takuya Ohtani; Omar Khan; Manu Setty; Sasikanth Manne; Shaun O'Brien; Pier Federico Gherardini; Ramin Sedaghat Herati; Alexander C Huang; Kyong-Mi Chang; Evan W Newell; Niels Bovenschen; Dana Pe'er; Steven M Albelda; E John Wherry
Journal:  Immunity       Date:  2018-05-15       Impact factor: 31.745

5.  Transcriptional insights into the CD8(+) T cell response to infection and memory T cell formation.

Authors:  J Adam Best; David A Blair; Jamie Knell; Edward Yang; Viveka Mayya; Andrew Doedens; Michael L Dustin; Ananda W Goldrath
Journal:  Nat Immunol       Date:  2013-02-10       Impact factor: 25.606

6.  LKB1, Salt-Inducible Kinases, and MEF2C Are Linked Dependencies in Acute Myeloid Leukemia.

Authors:  Yusuke Tarumoto; Bin Lu; Tim D D Somerville; Yu-Han Huang; Joseph P Milazzo; Xiaoli S Wu; Olaf Klingbeil; Osama El Demerdash; Junwei Shi; Christopher R Vakoc
Journal:  Mol Cell       Date:  2018-03-08       Impact factor: 19.328

7.  Slingshot: cell lineage and pseudotime inference for single-cell transcriptomics.

Authors:  Kelly Street; Davide Risso; Russell B Fletcher; Diya Das; John Ngai; Nir Yosef; Elizabeth Purdom; Sandrine Dudoit
Journal:  BMC Genomics       Date:  2018-06-19       Impact factor: 3.969

Review 8.  WNT/β-Catenin Signaling Pathway Regulating T Cell-Inflammation in the Tumor Microenvironment.

Authors:  Xin Li; Yanwei Xiang; Fulun Li; Chengqian Yin; Bin Li; Xisong Ke
Journal:  Front Immunol       Date:  2019-09-26       Impact factor: 7.561

Review 9.  Wnt signaling in cancer: therapeutic targeting of Wnt signaling beyond β-catenin and the destruction complex.

Authors:  Youn-Sang Jung; Jae-Il Park
Journal:  Exp Mol Med       Date:  2020-02-10       Impact factor: 8.718

10.  TOX is a critical regulator of tumour-specific T cell differentiation.

Authors:  Andrew C Scott; Friederike Dündar; Paul Zumbo; Smita S Chandran; Christopher A Klebanoff; Mojdeh Shakiba; Prerak Trivedi; Laura Menocal; Heather Appleby; Steven Camara; Dmitriy Zamarin; Tyler Walther; Alexandra Snyder; Matthew R Femia; Elizabeth A Comen; Hannah Y Wen; Matthew D Hellmann; Niroshana Anandasabapathy; Yong Liu; Nasser K Altorki; Peter Lauer; Olivier Levy; Michael S Glickman; Jonathan Kaye; Doron Betel; Mary Philip; Andrea Schietinger
Journal:  Nature       Date:  2019-06-17       Impact factor: 49.962

View more
  2 in total

1.  Shared and distinct biological circuits in effector, memory and exhausted CD8+ T cells revealed by temporal single-cell transcriptomics and epigenetics.

Authors:  Josephine R Giles; Shin Foong Ngiow; Sasikanth Manne; Amy E Baxter; Omar Khan; Ping Wang; Ryan Staupe; Mohamed S Abdel-Hakeem; Hua Huang; Divij Mathew; Mark M Painter; Jennifer E Wu; Yinghui Jane Huang; Rishi R Goel; Patrick K Yan; Giorgos C Karakousis; Xiaowei Xu; Tara C Mitchell; Alexander C Huang; E John Wherry
Journal:  Nat Immunol       Date:  2022-10-21       Impact factor: 31.250

2.  The Pioneer Transcription Factor Foxa2 Modulates T Helper Differentiation to Reduce Mouse Allergic Airway Disease.

Authors:  Diana C Yánez; Ching-In Lau; Eleftheria Papaioannou; Mira M Chawda; Jasmine Rowell; Susan Ross; Anna Furmanski; Tessa Crompton
Journal:  Front Immunol       Date:  2022-08-08       Impact factor: 8.786

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.